搜尋
SAB Biotherapeutics Inc
SABSW添加自選
0.015USD
+0.004+43.27%
收盤 07/02, 13:00（美東）報價延遲15分鐘
0.00總市值
--本益比TTM
關於 SAB Biotherapeutics Inc 公司
SAB Biotherapeutics, Inc. 是一家臨牀階段的生物製藥公司，專注於開發完全人源化、多靶點、高效免疫球蛋白 (IgG)，無需人類捐獻者或恢復期血漿，用於治療和預防免疫和自身免疫性疾病。該公司的主要資產 SAB-142 針對 1 型糖尿病 (T1D)，採用疾病改良治療方法。該公司利用先進的基因工程和抗體科學開發了轉染色體 (Tc) 牛，這是唯一一種具有人類人工染色體的轉基因動物，其 DiversitAb 藥物開發生產系統能夠生成多種特定靶向、高效、完全人源化 IgG，可滿足人類疾病中廣泛未滿足的嚴重需求。該公司的 SAB-176 管線計劃是一種多價、廣譜中和的 IgG 人源多克隆 IgG 治療候選藥物，正在開發中，用於治療或預防嚴重流感。
SAB Biotherapeutics Inc簡介
公司代碼SABSW
公司名稱SAB Biotherapeutics Inc
上市日期Jan 12, 2021
CEOMr. Samuel J. Reich
員工數量- -
證券類型Company Warrant
年結日- -
公司地址777 W 41St St
城市MIAMI BEACH
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編33140
電話13058452813
網址https://www.sab.bio/
公司代碼SABSW
上市日期Jan 12, 2021
CEOMr. Samuel J. Reich
SAB Biotherapeutics Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Erick J. Lucera
Mr. Erick J. Lucera
Independent Director
Independent Director
--
--
Mr. David Link
Mr. David Link
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Mr. Samuel J. Reich
Mr. Samuel J. Reich
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Andrew D. Moin
Mr. Andrew D. Moin
Independent Director
Independent Director
--
--
Ms. Katie Katherine Ellias
Ms. Katie Katherine Ellias
Independent Director
Independent Director
--
--
Dr. Alexandra Kropotova, M.D.
Dr. Alexandra Kropotova, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Christoph Bausch, Ph.D.
Dr. Christoph Bausch, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Eddie J. Sullivan, Ph.D.
Dr. Eddie J. Sullivan, Ph.D.
President, Director
President, Director
--
--
Dr. Jay S. Skyler, M.D.
Dr. Jay S. Skyler, M.D.
Independent Director
Independent Director
--
--
Ms. Lucy To
Ms. Lucy To
Chief Financial Officer
Chief Financial Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Erick J. Lucera
Mr. Erick J. Lucera
Independent Director
Independent Director
--
--
Mr. David Link
Mr. David Link
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Mr. Samuel J. Reich
Mr. Samuel J. Reich
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Andrew D. Moin
Mr. Andrew D. Moin
Independent Director
Independent Director
--
--
Ms. Katie Katherine Ellias
Ms. Katie Katherine Ellias
Independent Director
Independent Director
--
--
Dr. Alexandra Kropotova, M.D.
Dr. Alexandra Kropotova, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
常見問題
SAB Biotherapeutics Inc的前五大股東是誰？
SAB Biotherapeutics Inc的前五大股東如下：Mr. Erick J. Lucera